Cipepofol Patent Expiration

Cipepofol was first introduced by Haisco-Usa Pharmaceuticals Inc in its drug Cypsedo on Aug 27, 2026.


Cipepofol Patents

Given below is the list of patents protecting Cipepofol, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cypsedo US10729666 Use Of Gabaa Receptor Reinforcing Agent In Preparation Of Sedative And Anesthetic Medicament May 06, 2034 Haisco
Cypsedo US9517988 Phenol Derivative And Preparation Method And Use In Medicine Thereof May 06, 2034 Haisco



Cipepofol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Cipepofol Generic API Manufacturers

Given below is the list of companies who have filed for Cipepofol generic, along with the locations of their manufacturing plants worldwide.